FIELD: medicine.
SUBSTANCE: method for predicting the nature of the flow of acantholytic pomace in patients with an isolated form of pemphigus of the oral cavity involves determining in the oral fluid the content of interleukin-4 (IL-4), interleukin-6 (IL-6) and interleukin-1β (IL-1β) and with values of IL-6 1.9 pg/ml and lower, IL-1β 87 pg/ml and below, and IL-4 46 pg/ml and higher, the probability of the transition to severe disease is predicted.
EFFECT: invention refers to dermatology, dentistry and clinical laboratory diagnostics.
1 cl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR EVALUATING CLINICAL EFFECTIVENESS IN PATIENTS WITH ISOLATED FORM OF ACANTHOLYTIC VESICULAR DISEASE OF ORAL CAVITY | 2018 |
|
RU2688212C1 |
| METHOD FOR PREDICTION OF VARIABILITY OF PEMPHIGUS CLINICAL FORM | 2008 |
|
RU2386400C1 |
| METHOD FOR PREDICTION OF CLINICAL COURSE OF AUTOIMMUNE PEMPHIGUS | 2010 |
|
RU2429482C1 |
| METHOD OF TREATING LICHEN ACUMINATUS IN ORAL MUCOSA | 2011 |
|
RU2510269C2 |
| APPLICATION OF SELECTIVE IMMUNOSORBENT FOR REMOVAL OF ANTIBODIES TO TYPE 3 DESMOGLEIN FROM BLOOD SERUM OF PATIENTS WITH VESICULAR FEVER | 2016 |
|
RU2627652C1 |
| METHOD OF ASSESSING CLINICAL EFFECTIVENESS IN CHRONIC GENERALISED PERIODONTITIS | 2010 |
|
RU2425376C1 |
| PEMPHIGUS SIMULATION METHOD FOR MICE BY IMMUNOGLOBULIN G ADMINISTRATION | 2015 |
|
RU2613718C1 |
| METHOD FOR PREDICTION OF EROSION OF VAGINAL MUCOSA AFTER SURGICAL CORRECTION OF GENITAL PROLAPSE WITH USING MESH IMPLANTS IN POSTMENOPAUSAL WOMEN | 2020 |
|
RU2737651C1 |
| METHOD FOR PREDICTING ACANTHOLYTIC PEMPHIGUS RECURRENCE | 2001 |
|
RU2199127C1 |
| ACANTHOLYTIC PEMPHIGUS TREATMENT METHOD | 2009 |
|
RU2391984C1 |
